ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.014,85
-1,05%
S&P 500
5.058,93
-1,12%
US Dollar vs BRL
5,1879
1,36%
Bitcoin
59.935,16
-6,11%
Brent Oil
86,015
-1,46%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) Notícias

ASMB

Assembly Biosciences (ASMB)

Assembly Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ASMB
DataHoraFonteTítuloCódigoCompanhia
28/03/202417:05GlobeNewswire Inc.Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
08/02/202410:00GlobeNewswire Inc.Assembly Biosciences Announces Effective Date of Reverse Stock SplitNASDAQ:ASMBAssembly Biosciences Inc
02/02/202418:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
19/01/202413:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
04/01/202410:00GlobeNewswire Inc.Assembly Biosciences Provides Anticipated Development Milestones for 2024NASDAQ:ASMBAssembly Biosciences Inc
21/12/202318:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ASMBAssembly Biosciences Inc
21/12/202318:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202318:10Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202318:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
22/11/202318:12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
10/11/202318:05GlobeNewswire Inc.Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ASMBAssembly Biosciences Inc
10/11/202310:00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
08/11/202318:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
08/11/202318:05GlobeNewswire Inc.Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent UpdatesNASDAQ:ASMBAssembly Biosciences Inc
08/11/202310:00GlobeNewswire Inc.Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical OfficerNASDAQ:ASMBAssembly Biosciences Inc
31/10/202317:19Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ASMBAssembly Biosciences Inc
17/10/202309:44Dow Jones NewsAssembly Biosciences Shares Soar Premarket on Gilead PactNASDAQ:ASMBAssembly Biosciences Inc
17/10/202308:51Dow Jones NewsGilead Taking Stake in Assembly Bio Under Antiviral CollaborationNASDAQ:ASMBAssembly Biosciences Inc
17/10/202308:00Business WireGilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral DiseasesNASDAQ:ASMBAssembly Biosciences Inc
11/10/202309:00GlobeNewswire Inc.Assembly Biosciences to Present New Data at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
03/10/202320:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASMBAssembly Biosciences Inc
02/10/202309:00GlobeNewswire Inc.Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry InhibitorNASDAQ:ASMBAssembly Biosciences Inc
19/09/202317:05GlobeNewswire Inc.Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV MeetingNASDAQ:ASMBAssembly Biosciences Inc
09/08/202317:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ASMBAssembly Biosciences Inc
09/08/202317:05GlobeNewswire Inc.Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent UpdatesNASDAQ:ASMBAssembly Biosciences Inc
17/07/202309:00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Herpes Simplex Virus Development Candidate ABI-5366 at the 47th Annual International Herpesvirus WorkshopNASDAQ:ASMBAssembly Biosciences Inc
23/06/202320:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASMBAssembly Biosciences Inc
21/06/202309:00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Entry Inhibitor and Core Inhibitor Programs at EASL’s International Liver Congress™ 2023NASDAQ:ASMBAssembly Biosciences Inc
07/06/202309:00GlobeNewswire Inc.Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL International Liver Congress™ 2023NASDAQ:ASMBAssembly Biosciences Inc
30/05/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ASMBAssembly Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ASMB

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
TECN3
TECHNOS ON
BOV
EMAE4
EMAE PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
GOLL4
GOL PN
BOV
OIBR3
OI ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
COGN3
COGNA ON
BOV
LUPA3
LUPATECH ON
BOV
HAGA3
HAGA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
SGPS3
SPRINGS ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
BRKM5
BRASKEM PNA
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados